Advertisement
Screener

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax

1.6 / 5 stars · 37/115 Roast Me

INTEGRA LIFESCIENCES HOLDINGS CORP Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax of -$40.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Income Statement › Other Income

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax · last filed 2026-02-26

  • INTEGRA LIFESCIENCES HOLDINGS CORP other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for fiscal 2025 was -$40.90M, a 175.90% decline from fiscal 2024.
  • INTEGRA LIFESCIENCES HOLDINGS CORP other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for fiscal 2024 was $53.88M.
  • INTEGRA LIFESCIENCES HOLDINGS CORP other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for fiscal 2023 was -$13.42M, a 171.18% decline from fiscal 2022.
  • INTEGRA LIFESCIENCES HOLDINGS CORP other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, before tax for fiscal 2022 was $18.86M, a 10.78% increase from fiscal 2021.
Period endOther Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax 12 month
2025-12-31-$40.90M
10-K · filed 2026-02-26
2024-12-31$53.88M
10-K · filed 2026-02-26
2023-12-31-$13.42M
10-K · filed 2026-02-26
2022-12-31$18.86M
10-K · filed 2025-02-25
2021-12-31$17.02M
10-K · filed 2024-02-28
2020-12-31-$24.44M
10-K · filed 2023-02-22
2019-12-31$14.87M
10-K · filed 2022-02-24
2018-12-31$13.40M
10-K · filed 2021-02-23
2017-12-31$2.96M
10-K · filed 2020-02-21
2016-12-31$0.00
10-K · filed 2019-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92